Rayno Biopharmaceutical Update: CBST,IMGN,REGN,VPHM and Large Caps Rule
Biotech Remains Strong But Momentum Is Easing Biotechnology stocks were positive today but major ETFs mixed with the FBT ($63.82) off 1.45%. Profit taking has hit some high fliers (AEGR,INCY) and many of our portfolio stocks are off their recent highs. Small and mid-caps are being sold off...
Rayno Biopharmaceutical Portfolio Nov. 1, 2013 YTD Performance…Update 1
Updated 2/11/15 see chart below Rayno 2013 Picks Outperform Biotechnology Indices and Funds Biopharmaceutical stocks hit all time highs in 2013 with major ETFs up as follows YTD: FBT ($65) up 41%, IBB ($206) up 50%, and XBI ((%120) up 36%. The Five Star Fidelity Select Biotechnology Fund...
Rayno Life Science Scoreboard- October 2013- Amidst Sell-Off
Equities: The Only Game in Town With Rates Under 3%? October, normally a month to be cautious on the market, proved that trends can be misleading even in the midst of turbulent times in Washington. DOW Up 2.5%, S&P Up 3.5%, NASDAQ Up 2.5%. Healthcare stocks followed suit with the broadly...
Risk Rising in Mid and Small Cap Biopharmaceutical Stocks Update 2p EDT
Profit Taking Continues With Speculative Biotech Stocks Many of you who trade biopharmaceutical stocks know that $1B may be considered a small cap stock. As we mentioned in yesterday's post there is weakness in many high flying biotech stocks compared to the larger caps. Today the weakness is...
Biotechnology Bull Market Gets Second Wind To All Time Highs: ALR, GILD, ILMN,
Dow, S&P and Biotech Sector Hit All Time Highs NASDAQ Still 1000+Pts Under 2000 High Levels After a 10% sell-off in early October many large cap biopharmaceutical and diagnostic stocks are at new highs with the major indices at or near their October highs. The bellwether ETF IBB ($211.30)...